-

Mexedia S.p.A. Società Benefit: Renewal of the Appointments of the Board Committees

ROME--(BUSINESS WIRE)--Regulatory News:

Mexedia S.p.A. Società Benefit (ticker: ALMEX, ISIN: IT0005450819), announces that the Board of Directors ratified the renewal of the appointments of the Board Committees.

Share

Mexedia S.p.A. Società Benefit (ticker: ALMEX, ISIN: IT0005450819), announces that the Board of Directors, during its meeting held on 11 December 2025, ratified the renewal of the appointments of the Board Committees.

The Board Committees represent a key element of the Company’s corporate governance framework and provide advisory and propositional support to the Board of Directors, contributing to transparency, effective decision-making processes and appropriate oversight of the main strategic and control areas.

The appointments approved by the Board of Directors are as follows:

Nomination and Remuneration Committee

  • Augusto Pellegrini (Chairperson), Letizia Macrì, Daniel Gilcher

Control and Risk Committee

  • Augusto Pellegrini (Chairperson), Letizia Macrì, Daniel Gilcher

Related Party Transactions Committee

  • Letizia Macrì (Chairperson), Augusto Pellegrini, Daniel Gilcher

Innovation and Sustainability Committee

  • Letizia Macrì (Chairperson), Daniel Gilcher, Augusto Pellegrini

The Committees support the Board of Directors in its oversight and strategic guidance activities, strengthening governance in areas such as risk management, remuneration policies, related party transactions and the integration of innovation and sustainability into the Company’s strategy.

Paolo Bona, Chief Executive Officer of Mexedia, commented: “The renewal of the appointments of the Board Committees represents an important step to ensure effective oversight of the Company’s main governance areas. Through the work of the Committees, the Board of Directors can rely on structured support in its supervision, control and strategic guidance activities, fostering transparency and long-term value creation.”

About Mexedia

Mexedia S.p.A. Società Benefit is a joint-stock company listed on Euronext Growth Paris (ticker: ALMEX, ISIN: IT0005450819). The Group operates in the technology and digital services sector, with a focus on innovative solutions for communication between companies and customers. As a Società Benefit, Mexedia integrates social and environmental sustainability objectives into its business model, promoting responsible innovation and long-term value creation for all stakeholders.

Disclaimer – MAR and Forward-Looking Statements

This press release is disclosed pursuant to Article 17 of Regulation (EU) No. 596/2014 (Market Abuse Regulation – MAR). This press release may contain forward-looking statements regarding the Company’s objectives, strategies, outlook and expectations. Such statements are based on current assumptions and involve risks and uncertainties that may cause actual results to differ materially. Forward-looking statements are made as of the date of this press release and Mexedia undertakes no obligation to update them, except as required by applicable law.

Contacts

Vincenzo La Barbera
Investor Relations – Mexedia S.p.A. Società Benefit
investor.relations@mexedia.com

Mexedia S.p.A. Società Benefit

BOURSE:ALMEX
Details
Headquarters: Rome, Italy
CEO: Paolo Bona
Employees: 10
Organization: PUB

Release Versions

Contacts

Vincenzo La Barbera
Investor Relations – Mexedia S.p.A. Società Benefit
investor.relations@mexedia.com

More News From Mexedia S.p.A. Società Benefit

Mexedia S.p.A. Società Benefit: Management Discipline and Operational Approach in the Group’s Evolution Path

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of the evolution path initiated in 2024 and continued in 2025, confirms its commitment to strengthening management discipline and adopting an operational approach focused on efficiency, quality of activities and long-term sustainability. During the last financial year, the Group implemented a set of actions aimed at streamlining its operating perimeter and progressi...

Mexedia S.p.A. Società Benefit: Approval of the Draft Statutory and Consolidated Financial Statements as of December 31, 2025

ROME--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), meeting today, approved the draft statutory financial statements and the consolidated financial statements for the year ended December 31, 2025. ✓ Consolidated revenues at €118.1 million (+62.0% compared to €72.9 million in 2024) ✓ Gross margin at €10.2 million (+38.2% compared to €7.4 million in 2024) ✓ EBITDA at €-1.2 million (improving from €-23...

Mexedia Among the Leading Teams at Race for the Cure 2026

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819) is pleased to announce that, as part of its participation in the Race for the Cure 2026, the Mexedia & Friends team currently ranks fifth among the teams with the highest number of registered participants. This result continues to grow day by day and represents much more than a numerical milestone: an increasing number of people are choosing to join Mexedia & Friends...
Back to Newsroom